The gene-editing technology CRISPR shows early promise as a therapeutic strategy for the aggressive and difficult-to-treat brain cancer known as primary glioblastoma, according to findings of a new study from Gladstone Institutes.
History of IBD Linked to Severe Outcomes in Patients Hospitalized for COVID
LAS VEGAS — A history of inflammatory bowel disease (IBD) was associated with an increased risk of sepsis, shock, and acute kidney injury (AKI) in
February 2, 2024